PRP for Genitourinary Syndrome of Menopause: A Non-Hormonal Regenerative Approach
- drtskinhair
- Dec 30, 2025
- 5 min read
When Menopause Symptoms Go Beyond Hot Flashes
For many women, menopause is associated with symptoms like hot flashes, sleep disruption, and mood changes. But there is another group of symptoms that often remains unspoken — changes affecting vaginal and urinary discomfort. These symptoms may begin subtly during perimenopause or after menstruation has stopped completely. For many, the changes are initially dismissed as part of aging, but over time they can become persistent and disruptive.
Genitourinary syndrome of menopause (GSM) affects many women and is caused by hormonal changes that impact vaginal and urinary tissues. Symptoms such as dryness, irritation, painful intercourse, and urinary discomfort can affect daily comfort, confidence, and intimate relationships.
As awareness grows, more women are actively seeking supportive and effective GSM treatment options that do not rely solely on hormones. One emerging treatment option is PRP (platelet-rich plasma) for GSM, which focuses on tissue health rather than hormone replacement.
Understanding Genitourinary Syndrome of Menopause (GSM)
GSM is a chronic condition caused by declining estrogen levels during menopause. Estrogen plays a vital role in maintaining the structure, elasticity, and hydration of vaginal and urinary tissues. When estrogen levels decrease, these tissues gradually undergo changes that affect both comfort and function.
The vaginal lining becomes thinner and less elastic. Blood flow to the area decreases, collagen production slows, and the tissue’s ability to retain moisture diminishes. Over time, these changes can lead to symptoms such as:
Persistent vaginal dryness
Burning, itching, or irritation
Discomfort or pain during intimacy
Increased urinary urgency or frequency
Recurrent urinary tract infections
Unlike some menopausal symptoms that may improve over time, GSM symptoms often persist or worsen without treatment.
Why GSM Is Often Underdiagnosed and Undertreated
Despite how common GSM is, it remains underdiagnosed. Many women do not bring up symptoms during medical appointments, particularly if symptoms affect sexual health or urinary function. Others may feel uncomfortable discussing intimacy or assume nothing can be done.
Healthcare providers are increasingly emphasizing the importance of addressing GSM early, as early intervention may help prevent symptom progression and improve long-term comfort.
Why Some Women Prefer GSM Treatment Without Hormones
Topical estrogen therapy is widely used and effective for many women with GSM. However, it is not suitable for everyone. Reasons may include:
A history of hormone-sensitive cancer
Ongoing breast or uterine health concerns
Personal preference
Discomfort with long-term hormone use
As a result, interest has grown in non-hormonal menopausal vaginal atrophy treatment options that focus on restoring tissue health rather than altering hormone levels.
While over-the-counter moisturizers may provide temporary relief, they do not address the underlying tissue changes associated with menopause. This has led many women to explore regenerative therapies such as PRP.
What Is PRP and Why Is It Used in Regenerative Medicine?
Platelet-rich plasma (PRP) is created from a small sample of the patient’s own blood. After processing, the plasma contains a concentrated level of platelets, which are rich in growth factors involved in tissue repair and regeneration.
PRP has been used in various medical fields, including orthopedics, sports medicine, dermatology, and gynecology. Its appeal lies in its ability to support the body’s natural healing processes without introducing foreign substances.
When used as PRP for genitourinary syndrome of menopause, PRP is applied to vaginal tissues in a controlled clinical setting with the goal of supporting:
Increased blood flow
Tissue thickness and elasticity
Moisture balance
Improved tissue resilience
How PRP for GSM Works at the Tissue Level
It is important to understand that PRP does not act like estrogen. Instead, PRP for genitourinary syndrome of menopause works by encouraging the body’s own regenerative response.
Growth factors in PRP may help improve tissue resilience and thickness over time. This regenerative process can support improved hydration, elasticity, and overall tissue health. Because PRP works gradually, results are not immediate and develop over several weeks to months.
Peer-reviewed studies indexed in PubMed suggest that PRP has regenerative effects in gynecologic applications, though individual outcomes can vary.
The PRP Procedure for GSM: What to Expect
PRP treatment for GSM is performed in a clinical setting and generally follows a structured process:
A small blood sample is drawn
The blood is processed to isolate platelet-rich plasma
PRP is carefully applied or injected into targeted vaginal tissues
Local numbing measures are typically used to ensure comfort. The procedure is usually well tolerated, and most patients are able to resume normal activities the same day.
Recovery, Healing, and the Importance of Patience
One of the advantages of PRP treatment is minimal downtime. Some patients experience mild sensitivity, pressure, or fullness in the treated area shortly after treatment. These sensations typically resolve quickly.
Because PRP works through tissue regeneration, patience is essential. Improvements often appear gradually, with continued changes over several weeks. In some cases, a series of treatments may be recommended to support optimal results.
Who May Benefit Most from PRP for GSM?
PRP may be considered for women who:
Experience vaginal dryness, irritation, or discomfort related to menopause
Are seeking GSM treatment without hormones
Prefer non-surgical, regenerative approaches
Have not achieved sufficient relief with topical products
A personalized consultation is essential to assess suitability, review medical history, and discuss expectations.
Setting Realistic Expectations and Understanding Limitations
While PRP offers a promising regenerative approach, it is not a cure for menopause or GSM. Not all patients experience the same degree of improvement, and results can vary based on tissue health, age, and symptom severity.
Responsible care involves setting realistic expectations and discussing alternative or complementary treatment options when appropriate. PRP may be most effective as part of a broader care plan rather than a standalone solution.
Frequently Asked Questions (FAQ)
How long do results from PRP for genitourinary syndrome of menopause last?
Results vary, but improvements may last several months. Maintenance treatments may be recommended depending on symptom recurrence.
Is PRP treatment painful?
Most patients report minimal discomfort. Local numbing techniques are commonly used to enhance comfort.
How many PRP sessions are usually needed?
Some patients benefit from one session, while others may require a series of treatments spaced several weeks apart.
Is PRP safe for menopausal women?
Because PRP is derived from the patient’s own blood, the risk of allergic reaction is very low. Suitability must still be assessed individually.
Can PRP replace estrogen therapy for GSM?
PRP does not replace estrogen. It may be considered when hormone therapy is not suitable or desired.
When should other treatments be considered?
If symptoms are severe or related to other medical conditions, alternative or complementary treatments may be more appropriate.
Conclusion: A Regenerative Option Worth Discussing
Genitourinary syndrome of menopause is a common condition that deserves compassionate, individualized care. For women seeking non-hormonal options, PRP for genitourinary syndrome of menopause offers a regenerative approach focused on improving tissue health and comfort over time.
At Dr. T Aesthetics in London, ON, we offer PRP as part of an individualized approach to intimate wellness. If you’re looking for a hormone-free option to improve comfort and confidence, book a consultation to review candidacy, expected outcomes, and aftercare.
References
North American Menopause Society (NAMS) – GSM Clinical Guidance
American College of Obstetricians and Gynecologists (ACOG)
PubMed (indexed literature): Platelet-Rich Plasma Applications in Gynecology
Comments